Phase 2 × Rectal Neoplasms × Chemotherapy, Adjuvant × Clear all COCHISE
Phase 2 Terminated
18 enrolled 9 charts
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
Phase 2 Unknown
150 enrolled
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
Phase 2 Terminated
19 enrolled
Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy
Phase 2 Unknown
99 enrolled
Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma
Phase 2 Terminated
5 enrolled 6 charts
Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
Phase 2 Completed
Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer
Phase 2 Completed
49 enrolled 5 charts
COPERNICUS
Phase 2 Completed
60 enrolled
Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer
Phase 2 Terminated
22 enrolled 10 charts
Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Phase 2 Terminated
39 enrolled 9 charts
Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer
Phase 2 Completed
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
Phase 2 Unknown
100 enrolled
EXPERT-C
Phase 2 Unknown
164 enrolled
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
Phase 2 Unknown
35 enrolled
Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown